Chicago, Illinois, USAMore info Poster: Intergroup ALFA/GOELAMS Randomized Phase II Trial of Lirilumab as Maintenance Treatment in Elderly Patients with AML 622.3 KB Poster BMS : A Phase I Study of Lirilumab (BMS-986015), an Anti-KIR Monoclonal Antibody, Administered with Ipilimumab... 2.59 MB Poster BMS : A Phase 1 Dose-escalation and Cohort Expansion Study of Lirilumab Administered in Combination With Nivolumab... 1.88 MB Date Fri, 05/31/2013 - 08:00
